Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microscopic polyangiitis with ocular involvement

J C Caster1, D J Shetlar, M A Pappolla

  • 1Department of Ophthalmology, University of Texas Houston Health Science Center, USA.

Archives of Ophthalmology (Chicago, Ill. : 1960)
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis.

Current Alzheimer research·2018
Same author

A unique case of limb-girdle muscular dystrophy type 2A carrying novel compound heterozygous mutations in the human CAPN3 gene.

European journal of neurology·2007
Same author

Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology.

Neurology·2003
Same author

Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide.

Biochemistry·2001
Same author

Black cutworm (Lepidoptera: Noctuidae) larval emigration and biomass in mixtures of endophytic perennial ryegrass and Kentucky bluegrass.

Journal of economic entomology·2001
Same author

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Neurobiology of disease·2001
Same journal

The economics of the initial preventive physical examination in medicare-reply.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

Modification of silicone oil retention sutures in aphakic eyes with iris loss-reply;.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

December 2011 archives web quiz winner.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

Angle involvement and glaucoma in patients with biopsy-proven iris melanoma: a response-reply.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

About this journal.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

In memoriam: goodwin m. Breinin, MD (1918-2011).

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
See all related articles

Microscopic polyangiitis, a small-vessel vasculitis, typically affects kidneys and lungs. This case highlights rare eyelid and conjunctival involvement, successfully treated with immunosuppression.

Area of Science:

  • Rheumatology
  • Ophthalmology
  • Nephrology

Background:

  • Microscopic polyangiitis (MPA) is a systemic small-vessel vasculitis.
  • MPA characteristically affects the kidneys, lungs, skin, and nervous system.
  • Diagnosis involves identifying necrotizing vasculitis and perinuclear-staining antineutrophil cytoplasmic antibodies (P-ANCA).

Observation:

  • This report details a unique case of MPA presenting with eyelid and conjunctival manifestations.
  • These ocular findings are previously unreported in the literature for MPA.
  • The patient's condition showed significant improvement upon receiving immunosuppressive therapy.

Findings:

  • The case demonstrates that microscopic polyangiitis can manifest with unusual ocular symptoms.
  • Prompt diagnosis and treatment with immunosuppressants led to a favorable outcome.

Related Experiment Videos

  • This expands the known clinical spectrum of MPA.

    • Implications:

    • Highlights the importance of considering MPA in patients with unexplained ocular inflammation.
    • Suggests ophthalmologic evaluation may be crucial for comprehensive MPA diagnosis.
    • Emphasizes the efficacy of immunosuppressive therapy in managing diverse MPA presentations.